Evidence map›Paper›PMID 10708437›Full record

ArticleJournal of virology2000

Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.

R M Scoggins, J R Taylor, J Patrie, A B van't Wout, H Schuitemaker, D Camerini

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Clinical significance of HIV-1 coreceptor usage.Journal of translational medicine · 2011
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

R M ScogginsDepartment of Microbiology and Myles H. Thaler Center for AIDS and Human Retrovirus Research, Division of Biostatistics and Epidemiology, University of Virginia, Charlottesville, Virginia 22908, USA.
J R Taylor
J Patrie
A B van't Wout
H Schuitemaker
D Camerini
Dutch Blood Transfusion Society · NLUniversity of Virginia · US

Funding

SYSTEMATIC DEVELOPMENT OF IMPROVED RNA INHIBITORS OF HIVP01AI040981 · NIAID · DUKE UNIVERSITY · PI GILBOA, ELI · 1997 to 2000
$630k
TESTING ANTIHIV-1 GENE THERAPY IN SCID-HU MICER29AI039943 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI CAMERINI, DAVID · 1996 to 2000
$76k
ANTI-REV GENE THERAPY FOR HIV-1 INFECTIONR01AI038186 · NIAID · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI REKOSH, DAVID M · 1996 to 1999
–
NIAID NIH HHS AI38186NIAID NIH HHS AI39943NIAID NIH HHS AI40981
6 · The paper itself

Abstract

We studied the replication and cytopathicity in SCID-hu mice of R5 human immunodeficiency virus type 1 (HIV-1) biological clones from early and late stages of infection of three patients who never developed MT-2 cell syncytium-inducing (SI; R5X4 or X4) viruses. Several of the late-stage non-MT-2 cell syncytium-inducing (NSI; R5) viruses from these patients depleted human CD4(+) thymocytes from SCID-hu mice. Earlier clones from the same patients did not deplete CD4(+) thymocytes from SCID-hu mice as well as later clones. We studied three R5 HIV-1 clones from patient ACH142 in greater detail. Two of these clones were obtained prior to the onset of AIDS; the third was obtained following the AIDS diagnosis. In GHOST cell infection assays, all three ACH142 R5 HIV-1 clones could infect GHOST cells expressing CCR5 but not GHOST cells expressing any of nine other HIV coreceptors tested. Furthermore, these patient clones efficiently infected stimulated peripheral blood mononuclear cells from a normal donor but not those from a homozygous CCR5Delta32 individual. Statistical analyses of data obtained from infection of SCID-hu mice with patient ACH142 R5 clones revealed that only the AIDS-associated clone significantly depleted CD4(+) thymocytes from SCID-hu mice. This clone also replicated to higher levels in SCID-hu mice than the two earlier clones, and a significant correlation between viral replication and CD4(+) thymocyte depletion was observed. Our results indicate that an intrinsic property of AIDS-associated R5 patient clones causes their increased replication and cytopathic effects in SCID-hu mice and likely contributes to the development of AIDS in patients who harbor only R5 quasispecies of HIV-1.

Indexed as

AnimalsCD4-CD8 RatioCytopathogenic Effect, ViralHIV-1HIV InfectionsHomozygoteHumansLiverMiceMice, SCIDReceptors, CCR5Thymus GlandVirus ReplicationReceptors, CCR5

Identifiers

PMID10708437
PMCPMC111821
OpenAlexW2111498525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.